跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 155 条关于
“Proscia”
全部
155
临床试验
136
药物
3
机构
5
资讯
11
去年
Proscia Launches AI-Powered Pathology Platform to Accelerate Precision Medicine Research
3个月前
Proscia Launches Fifth-Generation Concentriq Platform, Embedding Multimodal AI into Digital Pathology
去年
EMA Accepts Alvotech's Biosimilar AVT03 for Prolia and Xgeva
6个月前
Gossamer Bio's Seralutinib Fails Phase 3 PROSERA Trial Due to Stringent Statistical Threshold
10个月前
Gossamer Bio Advances Seralutinib Phase 3 Trials with PROSERA Results Expected February 2026
4个月前
ProEncia Biotechnology Secures Pre-Seed Funding to Advance Novel Periodontal Disease Treatment Pipeline
去年
Samsung Bioepis Receives Positive EMA Opinion for Denosumab Biosimilars Obodence and Xbryk
去年
Celltrion Presents Positive Phase 3 Data for Actemra and Prolia Biosimilars at ACR 2024
去年
FDA Accepts Biosimilar Applications for Denosumab from Organon and Teva
去年
FDA Accepts Biosimilar Applications for Denosumab from Organon and Teva
第 1 页,共 2 页
上一页
下一页